TrialAssure’s ANONYMIZE DS Patient Data Anonymization Tool Built with Machine Learning is Now Publicly Available

Posted onSeptember 19, 2019AuthorBusiness WireComments Off on TrialAssure’s ANONYMIZE DS Patient Data Anonymization Tool Built with Machine Learning is Now Publicly Available

BETHESDA, Md.--(BUSINESS WIRE)--TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today the full release of ANONYMIZE DS, the all-new software-as-a-service (SaaS) application that utilizes automation to anonymize sponsor’s clinical trial data, during the DIA Global Clinical Trial Disclosure and Data Transparency Conference. Gathering user feedback since its limited release February 2019, TrialAssure ANONYMIZE DS is now fully available to the public.

“As one of the first groups to automate the anonymization of datasets, our developers heard first-hand feedback from industry users during the limited release of the product and fine-tuned ANONYMIZE DS to best meet their needs,” says Zach Weingarden, Product Solutions Manager, TrialAssure. “As with all software we develop, our development team is open to engaging end users, actively encouraging feedback and listening carefully to their suggestions.”

Key features of TrialAssure ANONYMIZE DS, include:

Fits easily alongside other TrialAssure applications within the transparency suite of products, allowing for single dashboard reporting and synchronized workflows across all transparency related data and document deliverables

Transforming original data into anonymized data, using industry-standard techniques that can be reused and customized for each dataset

Assigning a risk score associated with the re-identification of this data based on thresholds set by the sponsor

Configurability to sponsor specifications

A simple user interface that allows for ease of transition from manual processes

Use of modern machine learning technology to drive efficiency

“All pharmaceutical sponsors will need to rely on anonymization methods, and therefore tools, to stay ahead of transparency regulations, as redaction of data limits data utility,” says Mohamad Zahreddine, CIO, TrialAssure, and member of the Forbes Technology Council. “Transparency experts and thoughtful developers have banded together, utilizing the latest technology to build a software application that is of great importance to the future of the pharmaceutical industry, and more broadly, all those in clinical research. We want global teams to #BeTransparent, and it’s in everyone’s best interest that while we must first protect privacy, the data shared should be usable.”

TrialAssure is a global clinical trial disclosure and transparency reporting suite with unmatched experience in helping clients navigate complex regulatory submission and reporting challenges. TrialAssure helps meet regulatory compliance goals through a flexible, scalable, and streamlined platform that regularly adapts to ever-changing clinical trial disclosure requirements. Established in 2009, TrialAssure was built from the ground up as a single, integrated transparency system, and it is continually strengthened by the experience of leading pharmaceutical industry compliance experts. For more information, visit: www.trialassure.com.

Phrasee CEO and co-founder, Parry Malm, draws on five years of working with global brands to explain the technology phenomenon redefining marketing
PALM SPRINGS, Calif.–(BUSINESS WIRE)–Parry Malm, CEO and co-founder of Phrasee, is today launching a …

Perspectium DataSync is a Fully Managed, Cloud-Delivered Service that “Un-silos” ServiceNow Data
SAN DIEGO–(BUSINESS WIRE)–Perspectium, the pioneer of service management integration as a service, today announced two new products aimed at quickly and…